Poland - Anti-cancer agents

Description

The subject of the contract is the delivery of oncological drugs, aids and auxiliary equipment.
1 Cisplatin ready-made concentrate for solution preparation with a minimum physicochemical stability of 48h 10mg (1mg/ml) - 20 vials. 3 Cisplatin ready-made concentrate for solution preparation with minimum 48h 50mg (1mg/ml) - 150 vials. 2 Doxorubicine hydrochloride - ready solution for injection and infusion 50mg - 700 vials; 3 Doxorubicine hydrochloride - ready solution for injection and infusion 100mg - 300 vials.4 Doxorubicine hydrochloride - ready solution for injection and infusion 200mg - 100 vials; 1 Ifosfamide 1g - 40 vials; 2 Ifosfamide 2g - 80 vials. 400mg messenger solution or 200mg - 450 amp. 1 Vinorelbine ready-made concentrate for solution. 10mg - 120 vials.;2 Vinorelbine ready-made concentrate for solution. Solution 50 mg - 20 vials; Methotrexate ready-made solution. 50mg - 150 amps; Methotrexate 2.5mg tablets (op. 50) - 15 op. 1 Carboplatin - ready concentrate for solution for infusion 50mg - 500 vials; 2 Carboplatin - ready concentrate for solution for infusion 150mg - 260 vials; 3 Carboplatin - ready concentrate for solution for infusion 450mg - 300 vials.4 Carboplatin - ready-made concentrate for solution for infusion 600mg - 200 vials. 1 Docetaxel - prepared concentrate 20mg - 400 vials; 2 Docetaxel - prepared concentrate 80mg - 400 vials; 1 Dacarbazine 100mg - 80 vials; 2 Dacarbazine 200mg - 150 vials; 3 Dacarbazine 500mg - 150 vials. 10mg Vinblastine sulfate with solvent. - 120 vials. Vincristine sulfate 1mg finished concentrate - 250 vials. Bleomycin hydrochloride 15mg - 200 vials. 1 Mitomycin 20mg - 10 vials.;2 Mitomycin 10mg - 100 vials; 1 Palbociclib 70mg cap. (op. 21pcs) - 10 op.;2 Palbociclib 100mg cap. (op. 21pcs) - 20 op.;3 Palbociclib 125mg cap. (op. 21pcs) - 40 op.; 1 Cyclophosphamide 1g (substrate soluble in 0.9 % NaCl) - 600 vials; 2 Cyclophosphamide 200mg (substrate soluble in 0.9 % NaCl) - 600 vials; Cyclophosphamide 50mg of irrigation (op. 50pcs) - 40 op. Melphalan 2mg tablets (op. 25) - 50 op. Chlorambucil 2mg tablets (op. 25) - 60 op. 1 Etoposide - ready-made concentrate for preparation. 50mg solution - 50 vials; 2 Etoposide - ready-made concentrate for preparation. 100mg solution - 100 vials;3 Etoposide - ready-made concentrate for preparation. solution. 200mg - 200 vials.; 1 Fluorouracil solution. 5000mg, no yellowing after solution preparation for infusion and physico-chemical stability at least 48h after solution preparation for patient. - 1000 vials; 2 Fluorouracil solution. 1000mg, no yellowing after solution preparation for infusion and physico-chemical stability at least 48h after solution preparation for the patient. - 100 vials; Bicalutamide 50mg tablets (op. 28) - 100 op. Ondansetron hydrochloride 8mg (op. 5 ampoules) - 1500 op. Aprepitant 80mg 2 tabl.+125mg 1 tabl. - 100 op. 1 Filgrastim 30 million IU of ampoules. - 200 units;2 Filgrastim 48 million junctions per ampoule. - 250 pcs. Vemurafenib 240mg tabl. (op. 56 pcs.) - 60 op. Cobimetinib 20mg tabl. (op. 63) - 15 op. 1 Gemcitabine-ready concentrate solution for solution for infusion 2000mg - 300 vials; 2 Gemcitabine-ready concentrate solution for solution for infusion 1000mg - 300 vials; 3 Gemcitabine-ready concentrate solution for solution for infusion 200mg - 300 vials; 1 Calcium folinate solution. 500mg, diluted solution physically and chemically stable 48h - 200 vials; 2 Calcium folinate solution. 1000mg, diluted solution physically and chemically stable 48h - 800 vials; Paclitaxel solution. 300mg, solution stability after dilution over 24h - 850 vials. Ribociclib 200mg x 63 tabl. - 360 op. Darbepoetin alpha 500mcg - 200 pcs. Trastuzumab 600mg/5ml for subcutaneous administration - 600 vials. 1 Topotecan-concentrate solution 4mg - 50 vials; 2 Topotecan-concentrate solution 1mg - 210 vials. Temozolomide in capsules 5, 20, 100, 140, 180, 250mg - 200000 mg 1 Capecitabine 150mg tablets (op. 60) - 200 op.;2 Capecitabine 500mg tablets (op. 120) - 500 op. Cladribine solution. 10mg - 40 vials. 1 Epirubicin - ready-made concentrate for solution preparation. 10mg - 100 vials.;2 Epirubicin - ready-made concentrate for solution preparation. 50mg - 50 vials.3 Epirubicin - ready-made concentrate for solution preparation. 100mg - 25 vials; Imatinib 400mg tablets with registration in GIST (op. 90) - 50 op. 1 Irinotecan ready-made concentrate for preparation.Solution. 300mg - 600 vials; 2 Irinotecan ready-made concentrate for solution preparation. 100mg - 600 vials; 3 Irinotecan ready-made concentrate for solution preparation. 40mg - 250 vials.1 Citarabine solution. 100mg - 40 vials; 2 Citarabine solution. 500mg - 30 vials; 3 Citarabine solution. 1000mg - 80 vials; Fulvestran 500mg (2 pre-filled syringes 250mg each) - 200 op. 1 Oxaliplatin - ready-made concentrate for preparation. 50mg solution - 500 vials; 2 Oxaliplatin - ready-made concentrate for preparation. Solution. 100mg - 500 vials;3 Oxaliplatin - ready-made concentrate for preparation. Solution. 200mg - 500 vials; Doxorubicin in pegylated liposomes - ready-made concentrate for preparation. Solution. 20mg - 200 vials. Pegfilgrastim 6mg semi-automatic injector - 300 units. 1 Vinorelbine capsules 20mg - 1200 pcs; 2 Vinorelbine capsules 30mg - 700 pcs; Bortezomide 3.5mg - 650 vials. Netupitant 300mg + palonosetron 0.5mg - 100 pcs. 1 Erlotinib hydrochloride 150mg (op. 30 table) - 40 op.; 2 Erlotinib hydrochloride 100mg (op. 30 table) - 10 op.; 1 Cetuximab 100mg solution - 600 vials; 2 Cetuximab 500mg solution - 800 vials.Liposomal Doxorubicin 50mg powder and ingredients for concentrate preparation (op. 2 combo) At the beginning of ordering the above mentioned medicine, the ordering party requires 1 device for concentrate preparation - 100 op. Fludarabine phosphate 50mg concentrate in solution form - 40 amp. 1 Imatinib 400mg capsule (op. 30) - 10 op.; 2 Imatinib 100mg capsule (op. 60) - 5 op. 1 Sunitynib 12.5mg hard capsules (op. 28) - 30 op.;2 Sunitynib 25mg hard capsules (op. 28) - 30 op.;3 Sunitynib 50mg hard capsules (op. 28) - 60 op.1 Bewacizumab 100mg concentrate for solution preparation - 350 vials.;2 Bewacizumab 400mg concentrate for solution preparation - 350 vials. Sorafenib 200mg table topping. (op. 112pcs) - 80 op. 1 Lapatinib 250mg table of coating. (op. 140 pcs.) - 60 op. 2 Lapatinib 250mg table of coating (op. 70 pcs.) - 20 op.; 1 Panitumumab 100mg - 130 vials;2 Panitumumab 400mg - 130 vials; 1 Pemetrexed 100mg - 80 vials;2 Pemetrexed 500mg - 80 vials; Thalidomide 100mg (op. 30 pcs.) - 200 op. 1 Levofolinic acid 200mg - 400 vials; 2 Levofolinic acid 450mg - 400 vials; 1 5-Fluorouracil 500mg compatible with levofolinic acid - 100 vials; 2 5-Fluorouracil 1000mg compatible with levofolinic acid - 700 vials.;2 5-Fluorouracil 5000mg compatible with levofolinic acid - 100 vials; 1 Octreotide Acetis 30mg - 15 vials; 2 Octreotide Acetis 20mg - 5 vials; Lomustine cap. 40mg (op. 20 pcs.) - 10 pcs. Brentuximab vedotin 50mg - 70 pcs. Zoledronic acid amp. 4mg - 50 pcs. 1 Everolimus tabl. 5mg (op. 30 pcs.) - 30 op.; 2 Everolimus tabl. 10mg (op. 30 pcs.) - 30 op.; Lipegfilgraste 6mg - 250 syringe ampoules Rasburykaza 1.5mg (op. 3 pcs.) - 60 op. 1 Bendamustine Hydrochloride 25mg (op. 5 vial) - 40 op.; 2 Bendamustine Hydrochloride 100mg (op. 5 vial) - 50 op. 1 Ruxolytinib 5mg (op. 56 pcs.) - 10 op.; 2 Ruxolytinib 15mg (op. 56 pcs.) - 25 op.; 3 Ruxolytinib 20mg (op. 56 pcs.) - 10 op.; 1 Lenalidomide 5mg (op. 21pcs) - 20 op.;2 Lenalidomide 10mg (op. 21pcs) - 50 op.;3 Lenalidomide 15mg (op. 21pcs) - 40 op.;4 Lenalidomide 25mg (op. 21pcs) - 150 op. 1 Lanreotide 120mg/0,5ml amp. - 50 pcs;2 Lanreotidum 90mg/0,5ml amp.-sec. - 20 pcs;3 Lanreotide 60mg/0,5ml amp. - 5 pcs. Dexketoprofen 50mg/2ml (Op. 5amp.) - 200 op. Paclitaxel shunting devices - 2000 pcs. 1 Rituximab 100mg/10ml - 400 vials; 2 Rituximab 500mg/50ml - 250 vials; Abiraterone 500mg (Op. 60) - 150 op. 1 Pazopanib 400mg (op. 60) - 150 op.; 2 Pazopanib 200mg (op. 30) - 60 op.; Azacytidine 100mg - 800 op. Procarbazinum 50mg kaps. (op. 50 pcs.) - 20 op. 1 Elastomer pump for supply of disposable drugs; providing continuous flow of drug for 135 h at nominal volume of 270 ml; supply speed 2 ml/h comfortable oval shape with soft and durable outer layer, small size; filling port closed with luer lock and protected by a plug protecting against mechanical damage and contamination. Filling port integrated with non-returnable valve to prevent the drug from going back to the syringe. Infusion guide with clamp for stopping the infusion and 1.2 um particle filter with vent located at the end of the drain, end of the drain with luer lock end, closed by a plug. Maximum filling volume 295ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. - 120 pcs;2 Pump bag, with a possibility to attach it to the belt. - 120 pcs;3 Elastomer pump for the supply of disposable drugs; providing a continuous flow of drugs for 54 h at a nominal volume of 270 ml; supply speed of 5 ml/h comfortable oval shape with soft and durable outer layer, small size; filling port closed with luer lock and secured with a plug to protect against mechanical damage and contamination. Filling port integrated with non-returnable valve to prevent the drug from going back to the syringe. Infusion guide with clamp for stopping the infusion and 1.2 um particle filter with vent located at the end of the drain, end of the drain with luer lock end, closed by a plug. Maximum filling volume 295ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. - 200 pcs;4 Pump bag, with a possibility to attach it to the belt. - 200 pcs;5 Elastomer pump for the supply of disposable drugs; providing a continuous flow of drugs for 50 h at a nominal volume of 100 ml; supply rate of 2 ml/h comfortable oval shape with soft and durable outer layer, small size; filling port closed with luer lock and secured with a plug to protect against mechanical damage and contamination. Filling port integrated with non-returnable valve to prevent the drug from going back to the syringe. Infusion guide with clamp for stopping the infusion and 1.2 um particle filter with vent located at the end of the drain, end of the drain with luer lock end, closed by a plug. Maximum filling volume 125ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. - 250 pcs;6 Pump bag, with a possibility to attach it to the belt. - 250 pcs;7 Elastomer pump for supply of disposable drugs; providing continuous flow of drug for 25 h at nominal volume of 100 ml; supply speed 5 ml/h comfortable oval shape with soft and durable outer layer, small size; filling port closed with luer lock and secured with a plug to protect against mechanical damage and contamination. Filling port integrated with non-returnable valve to prevent the drug from going back to the syringe. Infusion guide with clamp for stopping the infusion and 1.2 um particle filter with vent located at the end of the drain, end of the drain with luer lock end, closed by a plug. Maximum filling volume 125 ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. - 600 pcs;8 Pump bag, with the possibility to attach it to the belt. - 600 pcs; 1 Axitinib 1mg (op. 56pcs) - 30 op.; 2 Axitinib 5mg (op. 56pcs) - 20 op.; Gephitinib 250mg (op. 30pcs) - 15 op. Bekssaroten 75mg capsule (op. 100 pcs.) - 30 op. Instruments for repeated collection from a flacon containing cytotoxic drug by aseptic technique, showing stability and compatibility with them (type Chemo-Aide or equivalent) - 600 pcs. 1 Crizotinib 250mg hard capsules (op. 60pcs) - 25 op.; 2 Crizotinib 200mg hard capsules (op. 60pcs) - 40 op. Denosumab 120mg solution of 1.7ml - 20 pcs. Anagrelide 0.5mg capsule, a drug used in the first and second wave, also in patients with kidney failure with creatinine clearance below 50ml/min. (op. 100) - 150 op. Temsirolimus 30mg concentrate + diss. - 100 units. 1 Dabrafenib 50mg hard cap (op. 28) - 10 op.;2 Dabrafenib 75mg hard cap (op. 120) - 39 op. 1 Trametinib 0.5mg coated cap (op. 30) - 5 op.;2 Trametinib 2mg coated cap (op. 30) - 39 op.; Olaparibum 50mg cap. (op. 448 pcs.) - 35 op. Obinutuzumab 1g/40ml concentrate for solution for vial infusion. - 50 pcs. Pertuzumab 420mg/14ml concentrate for solution for vial infusion. - 50 pcs. Nab-paclitaxel 100mg in powder form for suspension for infusion vials. - 250 pcs. 1 Trabectedin 0.25mg - 35 pcs; 2 Trabectedin 1mg - 35 pcs; Enzalutamide 40mg cap. (op. 112 pcs.) - 90 op. Fludarabine phosphate 10mg tabl. powl. (op. 20 pcs.) - 60 op. Alektinib 150mg caps. (op. 224) - 14 op. Dexamethasone phosphate 4mg/ml reimbursed in paclitaxel chemotherapy (op. 5amp.) - 150 op. 1 Nivolumab 40mg/4ml - 144 pcs;2 Nivolumab 100mg/10ml - 288 pcs; 1 Cabozantinib 20mg (op. 30 pcs) - 10 op.;2 Cabozantinib 40mg (op. 30 pcs) - 30 op.;3 Cabozantinib 60mg (op. 30 pcs) - 20 op.; 1 Anagrelidum 0.5mg (op. 100 pcs.) - 20 op.; 2 Anagrelidum 1mg (op. 100 pcs.) - 20 op.; 1 Trastuzumab 150mg - 200 pcs.; 2 Trastuzumab 420mg - 200 pcs; Ibrutinib 140mg (op. 90 pcs.) - 80 op. Pembrolizumab 100mg - 40 pcs. 1 Ozymertynib 40mg (op. 30 pcs.) - 15 op.;2 Ozymertynib 80mg (op. 30 pcs.) - 15 op.; Atezolizumab 1200mg/20ml - 50 pcs. Pixantron 29mg - 110 pcs. Pixantron 29mg - 110 pcs 4mg or 3mg or 2mg or 1mg (op. 21 pcs) - 45 op. 1 Trastuzumab emtunsine 100mg - 54 pcs; 2 Trastuzumab emtunsine 160mg - 54 pcs; Trastuzumab 150mg - 80 pcs. 1 Nintedanibum 150mg (op. 60 pcs.) - 20 op.;2 Nintedanibum 100mg (op. 120 pcs.) - 30 op.; 1 Afatinib 20mg (op. 28 pcs.) - 18 op.;2 Afatinib 30mg (op. 28 pcs.) - 18 op.;3 Afatinib 40mg (op. 28 pcs.) - 18 op.; 1 Venetoclass 10 mg tabl (op.14 10 op. 2 Venerex 50 mg table (op. 7 pcs.) - 10 op. 3 Venerex 100 mg x 7 tablets. - 10 op.;4 Venerex 100 mg x 14 pcs. - 10 op.;5 Venetoclax 100 mg x 112 table - 110 op. 1 Daratumumab 100 mg / 5ml - 200 pcs;2 Daratumumab 400 mg / 20ml - 300 pcs; 1 Afibercept 100 mg / 5ml vial. - 100 pcs;2 Afibercept 200 mg / 8ml vial. - 100 pcs; 1 Carfilzomib 10 mg vial. - 300 pcs;2 Carfilzomib 60 mg vial. - 100 pcs; 1 Typiracyl 6.14 mg + trifluridine 15 mg coating table. (op.20 pcs.) - 30 op.;2 Typiracyl 6.14 mg + trifluridine 15 mg table topping. (op.60) - 80 op.;3 Typiracyl 8.19 mg + trifluridine 20 mg table topping (op.20) - 60 op.;4 Typiracyl 8.16 mg + trifluridine 20 mg table topping (op.60) - 90 op. 1 Trastuzumab 150mg - 200 pcs;2 Trastuzumab 420mg - 200 pcs. 1 Closed system with needleless port for picking from bags with profiled finger holder. On one side, the device ends with a spike with wings for easy entry into the bag and an additional needleless port with a silicone, self-closing, flat membrane, on the other side, a port compatible with each infusion set, secured with a tether plug. Can be used for 600 activations. The device is suitable for repeated contact with blood, lipids, chemotherapeutics, chlorhexidine and alcohols. Free of latex, DEHP and metal parts. - 1000 units;2 Device for adding a drug solution to an infusion fluid bag. For administering the drug directly into the infusion fluid bag through a compatible connection to a syringe delivery device. The device enables the connection of a standard infusion set, sterile, separately packaged (individually) - 1000 pieces;3 Adapter to the vial for dissolving drugs and equalizing pressure in a closed system. For 13 mm diameter vials. Closed system for dissolving the freeze-dried drug and taking the solution from the syringe vial. It has a plastic needle cut lengthwise to allow maximum drug uptake from the vial, a double elastomeric membrane to ensure dry connections, and a 20 ml expanding external chamber. It protects against the leakage and release of aerosols and vapours of hazardous substances. PVC-free. It has an ONB code assigned by the FDA. - 500 pcs;4 Bag access device, compatible with the syringe device, operating in a system of elastomeric membranes ensuring dry connection. - 200 pcs;5 Needle-free device for safe transfer of medicines in a syringe with luer lock tip. A device (connector), enabling the collection of a cytostatic (cytotoxic) drug solution from the vial, safe transfer in the syringe and addition to the infusion liquid container or in place of an intravenous injection, creating a closed, sealed system with elastomeric membranes to ensure dry connections. PVC-free. The device has a mechanism that prevents it from being unscrewed from the syringe again. - 500 pcs;6 Universal needleless device for preparing and taking solutions from vials of different neck diameters, allowing multiple aseptic collection from a collecting container with a micro spike. It has a venting mechanism with a 0.2 micron bacterial hydrophobic filter which ensures pressure equalization in the vial when adding solvent to the vial and when taking the drug solution from it, as well as eliminating the formation of the drug solution aerosol. The design allows for easy and effective disinfection of the flat contact surface of the syringe-connector, and for easy and effective removal of the residual solution from the contact surface of the syringe-connector when the syringe is unscrewed, and prevents the contents of the vial from going back from the syringe when the syringe is unscrewed, even if there is an overpressure in the vial. A filter along the entire length of the gripping part of the instrument, which does not protrude beyond the cross-section and longitudinal section of the instrument body, which allows ergonomic work with the instrument. Application time of up to 7 days or 140 activations depending on what happens first, while maintaining the principles of proper disinfection. Volume of filling the whole system 0,28ml. Micro spike, i.e. a spike cut lengthwise to the half of its length, with a gutter that allows maximum drug intake from the vial, without losses. A spike with two opposite holes, one on top of the spike, the other half of its length. The design excludes the contact of the drug with PVC and aluminum, free of latex - 500 pcs; Rituximab 1400mg/11,7ml - 250 vials.

Opportunity closing date

24 July 2020

Value of contract

to be confirmed